无标籤阵列系统市场 - 全球行业规模、份额、趋势、竞争、机会和预测，2018-2028 年。按类型、按应用、最终用户、地区和竞争细分

预计在 2024 年至 2028 年的预测期内，无标籤阵列系统市场将以令人印象深刻的复合年增长率增长。这可归因于对个性化药物、快速药物输送、生物标誌物识别、特定疾病或病症中特定蛋白质标誌物的识别以及无标籤阵列系统市场作为药物发现研究工具的使用增加等因素的不断增长的需求。

对个性化医疗的需求不断增加

近年来，现代医学逐渐走向精准医学，以消除个体剂量的遗弃。无标记阵列系统消除了对染料、试剂、修饰细胞和标籤的需求，同时提供对活细胞实验中的内源性靶标极其敏感的数据。基于干涉的表面等离子共振（SPR）、扫描开尔文纳米探针、原子力显微镜等技术用于无标记检测。此外，作为个性化治疗工作流程的一部分，即使安装每年识别出的数千种潜在诊断生物标誌物中的少数，也需要临床高效的生物传感器技术来实时监测患者的多种生物标誌物。因此，无标记阵列系统非常重要，因此可以支持推动个性化医疗需求的市场增长。

生物医学系统对无标记阵列系统的需求不断增长

在生物医学和生物科学领域，对无标记阵列系统不断增长的需求得到了高度关注。科学、纳米技术和集成计算配置的进步和更新正在促进无标记阵列系统的发展，例如微阵列、无标记生物传感器阵列等。这些微阵列、无标记生物传感器技术有助于获得有效的清晰度— —疾病信号通路、生物标誌物筛选、药物发现、蛋白质分析、药物标靶识别等，因此有助于诊断过程，通过推动市场增长进一步增加市场需求。此外，製造商还致力于开发高效、准确的读出系统和细胞模型，以启动细胞和分子水平的机制和功能研究。

药物输送效率日益受到关注

基于无标记阵列系统和患者样本，领先的市场参与者正在生成生物相关数据，这进一步有助于改进药物开发。无标记方法，例如检测和测量折射率的局部变化，用于研究不同的相互作用，包括领先的市场参与者正在使用无标记阵列系统和患者样本生成生物相关数据，这进一步有助于改进药物开发分子及其受体。例如，质谱被用作一种无标记的药物输送方法。例如，默克基质辅助激光解吸/电离质谱成像(MALDI-MSI) 的科学家们对肽进行了鑑定，以确定其吸收、分布、代谢和排泄(ADME) 特性，从而随着利用率的提高而促进了市场增长。药物输送实践。

对原子力光谱的需求不断增长

原子力显微镜 (AFM) 因其先进的应用（包括诊断和癌症研究）而受到很高的需求。此外，AFM 在生理设置中对细胞进行关键操作的应用有助于研究活细胞的机械特性。此外，原子力显微镜 (AFM) 涉及最少的样品操作，因此是研究和研究生物材料（例如细菌、DNA、细胞和病毒）原生环境的有效工具。因此，利用 AFM 作为高分辨率研究工具来检查和识别肿瘤细胞的机械特性和超微结构，增强了对无标记阵列系统的市场需求。

可用的定制

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

• 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 覆盖市场。
  • 考虑学习的年份
  • 主要市场细分

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要行业合作伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量和验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球无标籤阵列系统市场展望。

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按类型（表面等离子体共振、生物层干涉测量、细胞介电光谱等）
  • 按应用（药物发现、蛋白质界面分析、抗体表征等）
  • 按最终用户（製药和生物技术公司、学术和研究所、合同研究组织等）
  • 按公司划分 (2022)
  • 按地区
• 产品市场地图

第 6 章：亚太地区全球无标籤阵列系统市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 类型
  • 应用
  • 最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国 。
  • 印度 。
  • 韩国
  • 日本
  • 澳大利亚

第 7 章：欧洲全球无标籤阵列系统市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 类型
  • 应用
  • 最终用户
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第 8 章：北美腐殖质生物刺激剂市场展望。

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 类型
  • 应用
  • 最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国全球无标籤阵列系统市场展望
    • 市场规模及预测
      • 按价值
    • 市场份额及预测
      • 类型
      • 应用
      • 最终用户
  • 墨西哥全球无标籤阵列系统市场展望
    • 市场规模及预测
      • 按价值
    • 市场份额及预测
      • 类型
      • 应用
      • 最终用户
  • 加拿大全球无标籤阵列系统市场展望
    • 市场规模及预测
      • 按价值
    • 市场份额及预测
      • 类型
      • 应用
      • 最终用户

第 9 章：南美洲全球无标籤阵列系统市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 类型
  • 应用
  • 最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲全球无标籤阵列系统市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 类型
  • 应用
  • 最终用户
  • 按国家/地区
• MEA：国家分析
  • 南非全球无标籤阵列系统
  • 沙特阿拉伯全球无标籤阵列系统
  • 阿联酋全球无标籤阵列系统
  • 科威特全球无标籤阵列系统

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 最近的发展
• 併购
• 产品开发

第13章：竞争格局

• 商业概览
• 公司概况
• 产品与服务
• 财务（上市公司）
• 最近的发展
• SWOT分析
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Becton, Dickinson and Company
  • Sartorius AG

第 14 章：战略建议

Label-free Array Systems Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing demand for personalized medicines, rapid drug delivery, biomarker identification, identification of specific protein markers in specific diseases or conditions, and increased usage of Label-free Array Systems Market as a research tool in drug discovery.

Without the use of fluorescent or radioactive labels, label-free array systems are analytical tools that are utilized to identify and quantify biomolecules in complicated samples. These devices work on the concept of Surface Plasmon Resonance (SPR), which enables the measurement of biomolecule binding to the array surface as well as changes in the reflected light.

Moreover, Label-free array systems are advantageous as there is no need for the use of hazardous or costly labeling agents, which makes them a safer and more affordable substitute compared to conventional labeling techniques. Label-free array devices can be used to analyze biomolecule interactions in real-time without the use of fluorescence or radioactivity, providing dynamic and quantitative data about the interacting molecules.

Increasing Demand for Personalized Medicine

In recent times, modern medicines are gradually moving towards precision medicine to eliminate individual dose dismissal. Label-free array systems eliminate the requirement for dyes, reagents, modified cells, and tags while providing data that is extremely sensitive for an endogenous target in live cell experiments. Techniques such as Interference-based Surface Plasmon Resonance (SPR), Scanning Kelvin Nanoprobe, Atomic Force Microscopy, etc., are utilized in label-free detection. Furthermore, installing even a few of the thousands of potential diagnostic biomarkers identified each year as part of personalized treatment workflows necessitates clinically efficient biosensor technologies to monitor multiple biomarkers in patients in real-time. In this way, the label-free array system is of great importance and is thereby adding to support the market growth driving personalized medicine demand.

Growing Demand for Label-Free Array Systems in Biomedical System

The growing demand for label-free array systems is highly observed in biomedical medicines along with biological sciences. Advancements and update in science, nanotechnology, and integrated computational configuration are promoting the development of label-free array systems such as microarrays, label-free biosensor arrays, etc. These microarray, label-free biosensor techniques are helpful in getting efficient clarity of- disease signaling pathways, biomarker screening, drug discovery, protein profiling, drug target identification, etc., and are therefore aiding the diagnostic process, which is further adding to the market demand by propelling the market growth. Also, Manufacturers are focusing on developing efficient and accurate readout systems and cellular models with respect to launching mechanisms and functional studies on cellular and molecular levels.

Rising Focus on Drug Delivery Efficiency

Based on the Label-Free Array Systems and patient samples, the leading market players are generating biorelevant data, which further helps in improved drug development. The Label-free methods, like detection and measurement of a local change in refractive index, are utilized for studying distinct interactions comprising Leading market players are producing biorelevant data using Label-Free Array Systems and patient samples, which further aids in improved medication development drug molecules and their receptors. For instance, Mass Spectroscopy is utilized as a label-free approach to drug delivery. For Instance, scientists from Merck matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to peptides to identify their absorption, distribution, metabolism, and excretion (ADME) properties, thereby increasing the market growth with the rise in utilization for drug delivery practices.

Growing demand for Atomic Force Spectroscopy

Atomic Force Microscopy (AFM) is in high demand due to its advanced applications, including diagnosis and carrying cancer research. The applications of AFM to carry crucial operations on cells, moreover, in physiological setups, help in the study of the mechanical characteristics of the living cells. Also, Atomic Force Microscopy (AFM) includes the involvement of minimum sample manipulation and is, therefore, an efficient tool for the research and study of biological materials such as bacteria, DNA, cells, and viruses in their native environments. Hence, the market demand for label-free array systems is enhanced by the utilization of AFM to be employed as a high-resolution research tool to examine and identify the mechanical properties and ultrastructure of tumor cells.

Market Segmentation

Label-free Array Systems Market is segmented based on the type, application, end-user, and region. Based on type, the market is segmented into surface plasmon resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others. Based on application, the market is segmented into drug discovery, protein interface analysis, antibody characterization, and others. Based on end users, the market is further fragmented into pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and others. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, and Sartorius AG, etc.., are some of the major players operating in the Global Label-free Array Systems Market.

Report Scope

In this report, Global Label-free Array Systems Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Label-free Array Systems Market, By Type:

• Surface Plasmon Resonance
• Bio-layer Interferometry
• Cellular Dielectric Spectroscopy
• Others

Label-free Array Systems Market, By Mode:

• Automated ELISA Analyzers
• Semi-Automated Analyzers

Label-free Array Systems Market, By Application:

• Drug Discovery
• Protein Interface Analysis
• Antibody Characterization
• Others

Label-free Array Systems Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institute
• Contract Research Organization
• Others

Label-free Array Systems Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

• South America
  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Label-free Array Systems Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered.
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Label-free Array Systems Market Outlook.

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (surface plasmon resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others)
  • 5.2.2. By Application (Drug Discovery, Protein Interface Analysis, Antibody Characterization and Others)
  • 5.2.3. By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institute, Contract Research Organization and Others)
  • 5.2.4. By Company (2022)
  • 5.2.5. By Region
• 5.3. Product Market Map

6. Asia-Pacific Global Label-free Array Systems Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. Type
  • 6.2.2. Application
  • 6.2.3. End user
  • 6.2.4. By Country
• 6.3. Asia-Pacific: Country Analysis
  • 6.3.1. China Global Label-free Array Systems Market Outlook.
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. Type
      • 6.3.1.2.2. Application
      • 6.3.1.2.3. End user
  • 6.3.2. India Global Label-free Array Systems Market Outlook.
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. Type
      • 6.3.2.2.2. Application
      • 6.3.2.2.3. End user
  • 6.3.3. South Korea Global Label-free Array Systems Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. Type
      • 6.3.3.2.2. Application
      • 6.3.3.2.3. End user
  • 6.3.4. Japan Global Label-free Array Systems Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. Type
      • 6.3.4.2.2. Application
      • 6.3.4.2.3. End user
  • 6.3.5. Australia Global Label-free Array Systems Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. Type
      • 6.3.5.2.2. Application
      • 6.3.5.2.3. End user

7. Europe Global Label-free Array Systems Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. Type
  • 7.2.2. Application
  • 7.2.3. End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Global Label-free Array Systems Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. Type
      • 7.3.1.2.2. Application
      • 7.3.1.2.3. End user
  • 7.3.2. Germany Global Label-free Array Systems Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. Type
      • 7.3.2.2.2. Application
      • 7.3.2.2.3. End user
  • 7.3.3. United Kingdom Global Label-free Array Systems Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. Type
      • 7.3.3.2.2. Application
      • 7.3.3.2.3. End user
  • 7.3.4. Italy Global Label-free Array Systems Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. Type
      • 7.3.4.2.2. Application
      • 7.3.4.2.3. End user
  • 7.3.5. Spain Global Label-free Array Systems Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. Type
      • 7.3.5.2.2. Application
      • 7.3.5.2.3. End user

8. North America Humic-based bio stimulants Market Outlook.

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. Type
  • 8.2.2. Application
  • 8.2.3. End user
  • 8.2.4. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Global Label-free Array Systems Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. Type
      • 8.3.1.2.2. Application
      • 8.3.1.2.3. End user
  • 8.3.2. Mexico Global Label-free Array Systems Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. Type
      • 8.3.2.2.2. Application
      • 8.3.2.2.3. End user
  • 8.3.3. Canada Global Label-free Array Systems Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. Type
      • 8.3.3.2.2. Application
      • 8.3.3.2.3. End user

9. South America Global Label-free Array Systems Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. Type
  • 9.2.2. Application
  • 9.2.3. End user
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Global Label-free Array Systems Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. Type
      • 9.3.1.2.2. Application
      • 9.3.1.2.3. End user
  • 9.3.2. Argentina Global Label-free Array Systems Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. Type
      • 9.3.2.2.2. Application
      • 9.3.2.2.3. End user
  • 9.3.3. Colombia Global Label-free Array Systems Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. Type
      • 9.3.3.2.2. Application
      • 9.3.3.2.3. End user

10. Middle East and Africa Global Label-free Array Systems Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. Type
  • 10.2.2. Application
  • 10.2.3. End user
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Global Label-free Array Systems Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. Type
      • 10.3.1.2.2. Application
      • 10.3.1.2.3. End user
  • 10.3.2. Saudi Arabia Global Label-free Array Systems Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. Type
      • 10.3.2.2.2. Application
      • 10.3.2.2.3. End user
  • 10.3.3. UAE Global Label-free Array Systems Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. Type
      • 10.3.3.2.2. Application
      • 10.3.3.2.3. End user
  • 10.3.4. Kuwait Global Label-free Array Systems Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. Type
      • 10.3.4.2.2. Application
      • 10.3.4.2.3. End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Developments

13. Competitive Landscape

• 13.1. Business Overview
• 13.2. Company Snapshot
• 13.3. Products & Services
• 13.4. Financials (In case of listed companies)
• 13.5. Recent Developments
• 13.6. SWOT Analysis
  • 13.6.1. Illumina, Inc.
  • 13.6.2. Thermo Fisher Scientific, Inc.
  • 13.6.3. Agilent Technologies, Inc.
  • 13.6.4. PerkinElmer, Inc.
  • 13.6.5. Merck KGaA
  • 13.6.6. Danaher Corporation
  • 13.6.7. Bio-Rad Laboratories, Inc.
  • 13.6.8. F. Hoffmann-La Roche AG
  • 13.6.9. Becton, Dickinson and Company
  • 13.6.10. Sartorius AG

14. Strategic Recommendations